Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


CbdMD Therapeutics Announces Launch Of Animal Health Study In Collaboration With Colorado State University's Veterinary Program


Benzinga | Jun 3, 2021 10:01AM EDT

CbdMD Therapeutics Announces Launch Of Animal Health Study In Collaboration With Colorado State University's Veterinary Program

Study To Explore Effects of cbdMD's Proprietary Cannabinoid Blend On Pets Who Suffer From Osteoarthritis

cbdMD, Inc. (NYSE:YCBD, YCBDpA))))) (the "Company"), one of the leading, and most highly trusted and recognized cannabidiol (CBD) company, announced today that its recently formed subsidiary, cbdMD Therapeutics, has begun a collaboration with researchers at the Colorado State University (CSU) veterinary program, to explore the effects of the Company's patent pending, proprietary cbdMD branded cannabinoid blend on dogs that suffer from osteoarthritis. The results from this study will provide validating data on the efficacy of the Company's products in reducing pain and improving joint mobility in dogs. The Company expects the full study to be complete by the Spring 2022. cbdMD's Paw CBD brand is one of the leading CBD animal health brands in the U.S.

"It has been estimated that one in five dogs are diagnosed with osteoarthritis in their lifetime. With almost 1 billion dogs globally and over 75 million in the US, osteoarthritis effects millions of our loved ones. Paw CBD is committed to providing products that can improve our pet's quality of life and provide relief for joint discomfort for the millions of pets who suffer from this disease. Our partnership with CSU will serve as the foundation for future work where we will explore the clinical impact of our proprietary broad spectrum cannabinoid blend on pain and mobility in our pets," said Martin Sumichrast, Chairman and Co-CEO of cbdMD, Inc.

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products. Our cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes. Our Paw CBD brand of pet products includes over 45 SKUs of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and our CBD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care. To learn more about cbdMD and their comprehensive line of U.S. grown, THC-free1 CBD oil products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

1 THC-free is defined as below the level of detection using validated scientific analytical methods.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC